DETROIT, May 10, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to announce today it has developed an innovative hemostatic material which it has filed for provisional patent and is currently presenting to the biomedical industry.
The new innovation includes a nano biotechnology hemostatic mesh, which creates a mechanical barrier stopping blood flow in wounds and integrates both physical and chemical protection, and antibacterial properties.
The proprietary nano material is made with polyvinyl nanofibers, graphene oxide sheets and plate nanoparticles which combine to produce a water-soluble synthetic polymer which has excellent film forming quality, a high tensile strength and flexibility, and allows for emulsifying of additional biomedical enhancing materials that would otherwise not be able to be blended together.The result is a surgical mesh that allows blood platelets to adhere to the surface and offers physical and chemical protection to stimulate coagulation, and possess sustained release of antibacterial properties. The material is biocompatible, durable, and flexible enough to fit complex wounds, is stable and functional at extreme temperatures, has a long shelf life, and possesses antibacterial properties. "There have been a number of patented hemostatic materials that are based on the use of nanofibers. However, these patents do not include the use of graphene oxide and silver nanoparticles, which gives our new product antibacterial properties and mechanical reinforcement," states Dr. Castano, Chief Innovations Officer of Nano Labs. Silver's antimicrobial properties have been known for centuries and the bactericidal properties of silver nanoparticles are widely documented. Silver nanoparticles cause lysis of bacteria and do not pose a risk to the health of people. Graphene, which consists of carbon sheets (the thickness of a single atom), are used as a template for the assembly of the silver nanoparticles, enhancing the binding capacity of the nanoparticles and increasing its antimicrobial activity.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV